Drug Type CRISPR/Cas9 |
Synonyms- |
Target |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Scribe TherapeuticsStartup |
Active Organization Scribe TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | Scribe TherapeuticsStartup | 03 Oct 2024 |
Endocrinology and Metabolic Disease | Discovery | - | Scribe TherapeuticsStartup | 03 Oct 2024 |
Liver Diseases | Discovery | - | Scribe TherapeuticsStartup | 03 Oct 2024 |
Shock | Discovery | - | Scribe TherapeuticsStartup | 03 Oct 2024 |